Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders
Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Co-Chairs


George W. Sledge, Jr., MD
Ballve-Lantero Professor
of Oncology
Co-Director, Breast Cancer Program
Indiana University Cancer Center
Indianapolis, IN
Co-Chair, Breast Committee, The Eastern Oncology Cooperative Group (ECOG)

Dennis J. Slamon, MD, Ph.D.
Chief, Division of Hematology-Oncology
Professor and Executive Vice Chair, Department of Medicine
Director for Clinical Research
Johnson Comprehensive Cancer Center
Director, Revlon/UCLA Women’s Health Research and Cancer Research Programs
University of California at Los Angeles School of Medicine
Los Angeles, California

Organizing Committee

Julie R. Gralow, MD
Associate Professor of Medical Oncology
University of Washington School of Medicine
Cancer Care Alliance
Seattle, WA
Co-Chair, Breast Committee, The Southwest Oncology Group (SWOG)

Clifford A. Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Co-Chair, Breast Committee, The Cancer and Leukemia Group B (CALGB)

Mark Pegram ,MD
Professor of Medicine and Oncology
University of Miami Cancer Center
Miami, FL

Edith A. Perez, MD
Professor of Medicine
Director, Clinical Research,
Mayo Clinic
Jacksonville, FL
Chair, Breast Committee, The North Central Cancer Treatment Group (NCCTG)

Peter M. Ravdin, MD, PhD
Research Professor,
Department of Biostatistics
MD Anderson Cancer Center
Houston, TX

Eric P. Winer, MD
Director, Breast Oncology Center
Thompson Investigator in Breast Cancer Research
Department of Medical Oncology
Dana-Farber Cancer Institute /
Harvard Cancer Center
Boston, MA
Co-Chair, Breast Committee, The Cancer and Leukemia Group B (CALGB)

Additional Expert Faculty

Doctor

Sunil Badve, MD
Associate Professor of Pathology
Clarian Pathology Laboratory
Indiana University Cancer Center

Doctor

Donald A. Berry, PhD
Head, Division of Quantitative Sciences
Professor and Frank T. McGraw Memorial Chair for Cancer Research
Chairman, Department of Biostatistics
MD Anderson Cancer Center

Doctor

Powel H. Brown, MD, PhD
Professor of Medicine,
Baylor College of Medicine
Associate Director
of Cancer Prevention,
Dan L. Duncan Cancer Center
Director of Cancer Prevention and Population Sciences Program,
Dan L. Duncan Cancer Center
Associate Director of Research, Breast Center
Baylor College of Medicine

Doctor

Lisa A. Carey, MD
Medical Director, UNC Breast Center
University of North Carolina -
Lineberger Comprehensive Cancer Center

Doctor

Graham A. Colditz, MD, DrPh
Niess-Gain Professor
in the School of Medicine,
Department of Surgery,
Associate Director Prevention
and Control,
Alvin J. Siteman Cancer Center,
Washington University School of Medicine

Doctor

Armando E. Giuliano, MD
Chief of Science and Medicine
Breast and Endocrine Program
John Wayne Cancer Institute

Doctor

Richard J. Gralla, MD
President, Multinational Association of Supportive Care
in Cancer (MASCC)
Past President and Current Board Member, New York Lung Cancer Alliance
New York, NY

Doctor

David M. Loesch, MD
Private Practice
US Oncology
Indianapolis, IN

Doctor

Eleftherios P. Mamounas, MD, MPH, FACS
Professor of Surgery,
Northeastern Ohio Universities College of Medicine
Medical Director, Aultman Cancer Center,
Chairman, Breast Committee,
National Surgical Adjuvant Breast
and Bowel Project (NSABP)

Doctor

Olufunmilayo Olopade, MB, BS
Walter L. Palmer Distinguished Service Professor in Medicine and Human Genetics
Director, Hematology/Oncology
University of Chicago

Doctor

Soonmyung Paik, MD
Director, Division of Pathology National Surgical Adjuvant Breast
and Bowel Project (NSABP)

Doctor

Charles M. Perou, PhD
Associate Professor
Department of Genetics
University of North Carolina
At Chapel Hill

Doctor

Martine Piccart-Gebhart, MD, PhD
Head of the Chemotherapy Department
Jules Bordet Institute
President, European Organization for the Research and Treatment of Cancer (EORTC)

Doctor

Lori J. Pierce, MD
Vice Provost for Academic and Faculty Affairs Professor, Department of Radiation Oncology
University of Michigan

Doctor

Malcolm Pike, MD
Professor and Acting Chair, Flora L. Thornton Professor
USC Norris Cancer Center

Doctor

Kathleen I. Pritchard, MD
Chair of the Breast Cancer Site Group
Toronto-Sunnybrook Regional Cancer Center

Doctor

Lajos Pusztai, MD, DPhil
Associate Professor of Medicine
Department of Breast Medical Oncology
MD Anderson Cancer Center

Doctor

Mary Lou Smith
Co-chair,
ECOG Patient Representative Committee
Co-Founder,
Research Advocacy Network

Joseph A. Sparano, MD
Professor of Medicine,
Albert Einstein College of Medicine,
Director, Breast Evaluation Center,
Montefiore-Einstein Cancer Center

Doctor

Frank A. Vicini, MD
Chief of Oncology Service
Program Director, Radiation Oncology
William Beaumont Hospital

Doctor

Jeffrey N. Weitzel, MD
Professor of Medicine,
Medical Oncology
Director of Clinical Cancer Genetics and Cancer Screening and Prevention Program
City of Hope Comprehensive Cancer Center

 

 

Tell a friend about this symposium Print the Agenda Email the Agenda

A completely new concept in breast cancer symposia, integrating molecular diagnostics, personalized surgical and radiation techniques and chemotherapy, hormonal therapy and targeted therapeutics for improving breast cancer patient care.


CO-CHAIRS

George W. Sledge, Jr., MD
Ballve-Lantero Professor of Oncology
Co-Director, Breast Cancer Program
Indiana University Cancer Center, Indianapolis, IN
Co-Chair, Breast Committee, The Eastern Oncology Cooperative Group (ECOG)

Dennis J. Slamon, MD, PhD
Chief, Division of Hematology-Oncology
Professor and Executive Vice Chair, Department of Medicine
Director for Clinical Research
Jonsson Comprehensive Cancer Center
Director, Revlon/UCLA Women’s Health Research and Cancer Research Programs
University of California at Los Angeles School of Medicine
Los Angeles, California



ORGANIZING COMMITTEE

Julie R. Gralow, MD
Associate Professor of Medicine and Medical Oncology
University of Washington School of Medicine
Cancer Care Alliance, Seattle, WA
Co-Chair, Breast Committee, The Southwest Oncology Group (SWOG)

Clifford A. Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Co-Chair, Breast Committee, The Cancer and Leukemia Group B (CALGB)

Mark Pegram, MD
Professor of Medicine and Oncology
University of Miami Cancer Center
Miami, FL

Edith A. Perez, MD
Professor of Medicine
Director, Clinical Research, Mayo Clinic
Jacksonville, FL
Chair, Breast Committee, The North Central Cancer Treatment Group (NCCTG)

Peter M. Ravdin, MD, PhD
Research Professor
Department of Biostatistics
MD Anderson Cancer Center
Houston, TX

Eric P. Winer, MD
Director, Breast Oncology Center
Thompson Investigator in Breast Cancer Research
Department of Medical Oncology
Dana-Farber Cancer Institute /
Harvard Cancer Center
Boston, MA
Co-Chair, Breast Committee,
The Cancer and Leukemia Group B (CALGB)



   
Educational Statement of Need
Overview
Disclosure
Target Audience
Learning Objectives
CME Credit Information
Agenda
Faculty
Educational Grant Sponsorship Opportunities
Trump Sonesta Hotel Information
Registration
   

Disclosure Back to Top
DISCLOSURE STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Oncology Learning Center (OLC) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an OLC-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

FACULTY/STAFF DISCLOSURE
Coming Soon.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Oncology Learning Center does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official prescribing information for each product for discussion of approved indicated, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Educational Grants

Sincere appreciation is extended to the following companies for their generous support of this educational meeting:
Genentech BioOncology, Novartis, Bristol-Myers Squibb, Lilly, Abraxis BioScience, AstraZeneca, Genomic Health, Eisai, sanofi-aventis, Bayer, Onyx, AviaraDx, Abbott

© 2012 Biomedical Learning Institute
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.